SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-005851
Filing Date
2022-04-20
Accepted
2022-04-20 16:02:52
Documents
13
Period of Report
2022-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20220415.htm   iXBRL 8-K 56261
2 EX-10.1 allk-ex10_1.htm EX-10.1 100688
  Complete submission text file 0000950170-22-005851.txt   287968

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20220415_lab.xml EX-101.LAB 12890
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20220415.xsd EX-101.SCH 2492
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20220415_pre.xml EX-101.PRE 9543
7 EXTRACTED XBRL INSTANCE DOCUMENT allk-20220415_htm.xml XML 4515
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 22838026
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences